Clinical Trial

Tranexamic Acid in Nasal Mohs Reconstruction

Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated August 19, 2025 (before its estimated June 2026 completion). Its status may not reflect the trial's current state.
Summary
This study will be a prospective randomized control trial to evaluate the effects of subcutaneously administered TXA among patients undergoing nasal Mohs reconstruction with local flaps at VUMC.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2023-09-24; most recent amendment 2025-08-17.
Status change: Not Yet Recruiting → Recruiting 2024-05-09
Trial Details
NCT Number NCT06057675
Lead Sponsor Vanderbilt University Medical Center
Conditions Postoperative Bleeding, Skin Cancer Face
Enrollment 100 participants
Start Date 2024-03-19
Primary Completion 2026-06 (estimated)
Study Completion 2026-06 (estimated)
Updated on ClinicalTrials.gov 2025-08-19